|
USP18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.641300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.297100E-03 |
| Normal-vs-Stage2 |
7.177200E-01 |
| Normal-vs-Stage3 |
3.918600E-01 |
| Normal-vs-Stage4 |
2.610200E-02 |
| Stage1-vs-Stage2 |
1.474820E-01 |
| Stage1-vs-Stage3 |
1.631230E-01 |
| Stage1-vs-Stage4 |
7.424200E-01 |
| Stage2-vs-Stage3 |
7.554400E-01 |
| Stage2-vs-Stage4 |
1.479770E-01 |
| Stage3-vs-Stage4 |
1.960390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.756800E-03 |
| Normal-vs-AfricanAmerican |
8.758200E-01 |
| Normal-vs-Asian |
2.989200E-01 |
| Caucasian-vs-AfricanAmerican |
6.758500E-02 |
| Caucasian-vs-Asian |
7.897600E-01 |
| AfricanAmerican-vs-Asian |
2.901000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.233180E-01 |
| Normal-vs-Female |
2.233900E-04 |
| Male-vs-Female |
1.637860E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.912800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.100640E-01 |
| Normal-vs-Age(61-80Yrs) |
4.984300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.096020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.523200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.231620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.277800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.592350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.012600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.375200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.226200E-01 |
| Normal-vs-Grade 2 |
2.047900E-02 |
| Normal-vs-Grade 3 |
1.488080E-02 |
| Normal-vs-Grade 4 |
1.814050E-01 |
| Grade 1-vs-Grade 2 |
7.351000E-01 |
| Grade 1-vs-Grade 3 |
9.639800E-01 |
| Grade 1-vs-Grade 4 |
7.394200E-01 |
| Grade 2-vs-Grade 3 |
5.120200E-01 |
| Grade 2-vs-Grade 4 |
8.950000E-01 |
| Grade 3-vs-Grade 4 |
5.596200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.56651999999591E-05 |
| Normal-vs-ccB subtype |
4.225800E-01 |
| ccA subtype-vs-ccB subtype |
1.43220000003996E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.209800E-02 |
| Normal-vs-N1 |
3.985000E-01 |
| N0-vs-N1 |
9.019200E-01 |
|
|
